KalVista Pharmaceuticals, Inc. KALV

Full chart Compare
Set alert

Price alert · KALV

All alert types
27.00 USD 0.00 (+0.00%)

At closeJun 10, 2026, 4:00 PM EDT

26.99 -0.01 -0.04%

After hours · Jun 10, 4:00 PM ET

26.98 Day range 27.00
10.41 52-week range 27.00
YTD
+67.18%
1 year
+106.26%

Revenue & Expenses

Other Income → Expenses: $420.00KIncome Tax Benefit → Expenses: $7.13MExpenses → Selling, General & Admin: $183.74MExpenses → Research & Development: $55.64MGross Profit → Expenses: $67.54MRevenue → Gross Profit: $67.54MRevenue → Cost of Revenue: $6.08MNet Loss → Expenses: $164.29MOther Income$420.00KIncome Tax Benefit$7.13MGross Profit$67.54MNet Loss$164.29MCost of Revenue$6.08MExpenses$239.38MSelling, General & Admin$183.74MResearch & Development$55.64MRevenue$73.62M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KALV annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022FY 2021 Apr 30, 2021
229.34M182.33M56.24M30.73M50.59M
335.38M294.82M183.20M203.88M272.01M
338.09M130.46M22.18M18.79M14.82M
149.95M4.44M7.14M7.21M5.05M
-2.71M164.36M161.03M185.09M257.19M
KALV annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022FY 2021 Apr 30, 2021
-152.91M-89.23M-75.26M-78.13M-30.17M
91.02M-84.72M41.41M57.86M-147.65M
159.73M150.71M58.12M1.58M212.12M
-929.00K-443.00K-1.20M-931.00K-82.00K
100.48M-24.45M25.51M-19.86M34.80M